ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 371161 | Rec_0378750 | Lysozyme (EC 3.2.1.17) |
MRLVADVRRVVLLSLSFWMQVFGLAVLVLPELWYHVTGQDYDPNVAWWLGVLLLLAGIVGRVYQQGLSPWKEWLRIVAVAAIVFALALLLAWPSSAASLNDSPATEAQTLAIAVPFIAKEEGKSNHAYRDAVGIWTICYGSTRGVHANMLLNDQQCLDLLKIEVAQHRTGLHRYFTPSTIDIRLPATRDAAYTSLAYNVGPARAGKSTATRRLNAGDVAGGCQALTWFDRAGRRILRGLFERRKREKALCMVGQQ |
Mesorhizobium sp [Bacterium] |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase, Non-hemolytic |
- |
- | Qualitative functional evidence |
- | - |
NO |
| 371162 | Rec_0378751 | PEP |
PEP |
Trapa japonica [Plant] |
Anti-aging,Collagen boosting |
Women aged 41 to 57 years (Randomized clinical trial) |
- | ELISA; Migration assay |
32419813 | - |
YES |
| 371163 | Rec_0378752 | Meucin-22, MUC-22 |
FFGHLFKLATKIIPSLFQRKKE |
Mesobuthus eupeus [Animal] |
Antimicrobial, Antibacterial |
Escherichia coli ATCC 25922 |
7.95 μM | Inhibition-zone assay; lethal concentration (C_L) |
29599756 | - |
YES |
| 371164 | Rec_0378753 | C18 |
LWKIGKKIWRVLWNWR |
synthetic construct [Synthetic] |
Antimicrobial, Antifungal |
Candida albicans ATCC 10231 |
14.67 μM | MIC |
35531288 | - |
YES |
| 371165 | Rec_0378754 | Unnamed |
CF |
Actinopterygii [Animal]; Sus scrofa [Animal] |
Antihypertensive |
- |
- | - |
23871047 | - |
NO |
| 371166 | Rec_0378755 | HCV(1487-1500) |
RRGRTGRGRRGIYR |
Japanese encephalitis virus [Virus] |
Antiviral, Replication inhibitor |
Japanese encephalitis virus (Replication); Vero |
21.1 μM | Helicase assay |
18479669 | - |
YES |
| 371167 | Rec_0378756 | Brevinin-1RE1 |
FLPGLECVSGLKIVPTVFCAITRIC |
Rana exilispinosa [Animal] |
Antimicrobial, Antifungal |
Candida albicans ATCC 90028 |
2.5 μg/mL | MIC |
- | - |
YES |
| 371168 | Rec_0378757 | Peptide 19 |
RPDKPRPYLKRPRPPRPVR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative |
Staphylococcus aureus DSM 6247 |
64-128 μg/mL | MIC |
35223768 | - |
YES |
| 371169 | Rec_0378758 | Unnamed |
SNGRNAAADAKASQRIAPFLRDYCCRRHACTLICG |
not reported [other] |
Toxic, Cytotoxic |
- |
- | - |
22058133 | - |
NO |
| 371170 | Rec_0378759 | Unnamed |
KKK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Aspergillus niger ATCC 16404 |
512 μg/mL | MIC |
27606830;22006001;28203232;22578748;27486068;31581500;28767074;33003569 | - |
YES |
| 371171 | Rec_0378760 | QUB-1570 |
FLALALIGKAIAKLK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
methicillin-resistant Staphylococcus aureus NCTC 12493 |
4 μM | MIC |
35203845 | - |
YES |
| 371172 | Rec_0378761 | Aurein2.5 |
GLFDIVKKVVGAFGSL |
Litoria aurea [Animal] |
Anticancer, Cytotoxic |
Leukemia tumor cell line |
10-100 μM | LC50 |
10951191 | - |
YES |
| 371173 | Rec_0378762 | HYL-19 (Derived from HYL) |
GILSSWLKKLKKIIAK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative, Antifungal, Hemolytic |
human red blood cells |
400 μM | LC50 |
26998557 | - |
YES |
| 371174 | Rec_0378763 | Peptide 96 |
RWRWWWW |
synthetic construct [Synthetic] |
Hemolytic |
horse RBCs |
- | Hemolysis |
34021253 | - |
YES |
| 371175 | Rec_0378764 | Uncharacterized protein |
MAPDQLAADSMQTELEALQELACQEAAAHLMVFWPRAEFPRRGPDNVLRLGYGRDIERRPQTEDVARMALAADISRVSKTLERRTFVLLANQPQCQHKVGFLYAVADIIGVDRIRDWNELWTAAGRGDWHTVCLQLMALNWEALEGSQVDRRMAAGNLIFGLRDA |
Xanthomonas phage KPhi1 [Virus] |
Antimicrobial, Bacteriolytic enzyme, Non-hemolytic, Non-ribosomal |
- |
- | - |
- | - |
NO |
| 371176 | Rec_0378765 | Nigrocin-2GRb |
GLFGKILGVGKKVLCGLSGMC |
Odorrana grahami [Animal] |
Antimicrobial |
- |
- | - |
16621155 | - |
NO |
| 371177 | Rec_0378766 | B1-GG-C10 |
GGVKRFKKFFRKLKKSV |
synthetic construct [Synthetic] |
Antimicrobial, Anticancer |
MCF-7 |
9.6±0.4 μM | IC50 |
26083110 | - |
YES |
| 371178 | Rec_0378767 | FLAK50 Z2 |
FAFGKGIGKVGKKLL |
synthetic construct [Synthetic] |
Antimicrobial, Anticancer |
- |
- | - |
- | US 2011/0319336 A4 |
NO |
| 371179 | Rec_0378768 | Lysozyme (EC 3.2.1.17) |
MAKTIGEVRSFLDGLVGKVTVDKSDSGLNGQCVSLIKNLLEFVGAPNPYAARGNAKDIPNTYVSQGIAKVGAGTLNIAVSRNGGGGYGHVWVKIGSDSWQANWNGFAVKKNVGEVSITDILNLDQWISTSNAPSPGGKATTLSAKGEALIKKFEECVLTAYDLGDGMITIGWGHAEPKGQTNLVAGVTTWSQAQADEQFRKDIAGYVNTVNNYFTRSFNQNQFDAMVSFTYNCGTGVFGRDNWDKNASDSYITESIANYINKGSQFEEGLRRRRQEEINLFNTPVNGSEATKKEEEDMTEFAILYGTGVYYVCGTKMVPLTTATQWSVLRTVYEQVQEHKTGKATPIKVMDWRNNQATFDAYAKICGLK |
Enterococcus sp. 4G2_DIV0659 [Bacterium] |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase, Non-hemolytic |
- |
- | Qualitative functional evidence |
- | - |
NO |
| 371180 | Rec_0378769 | Nigrocin-1-OR1 |
GLLSGVLGAGKHIVCGLSGLC |
Odorrana grahami [Animal] |
Antimicrobial, Antibacterial |
Escherichia coli TOP10 |
4.81 dimensionless OD_ID | Mex pooled growth assay (OD_ID at 4.5 h; Wald-adjusted p=1) |
35260685 | - |
YES |